Anavex Life Sciences (AVXL) News Today $7.53 -0.10 (-1.31%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$7.44 -0.09 (-1.13%) As of 05/30/2025 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock AVXL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by PVG Asset Management CorpPVG Asset Management Corp increased its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 503.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 78,490 shares of the biotechnology company'sMay 27, 2025 | marketbeat.comTwo Sigma Investments LP Decreases Stock Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)Two Sigma Investments LP reduced its position in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 6.5% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 776,901 shares of the biotechnology company's stock afterMay 27, 2025 | marketbeat.comD. E. Shaw & Co. Inc. Purchases Shares of 105,130 Anavex Life Sciences Corp. (NASDAQ:AVXL)D. E. Shaw & Co. Inc. purchased a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 105,130 shares of the biotMay 26, 2025 | marketbeat.comRafferty Asset Management LLC Sells 64,985 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)Rafferty Asset Management LLC decreased its position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 46.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 74,601 shares of the biotechnology company'May 24, 2025 | marketbeat.comNoteworthy Tuesday Option Activity: TOL, AVXL, PIIMay 21, 2025 | nasdaq.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Shares Sold by Price T Rowe Associates Inc. MDPrice T Rowe Associates Inc. MD trimmed its holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 53.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 29,197 shares of the biotechnology company's stock aftMay 18, 2025 | marketbeat.comAnavex Life Sciences Corp.'s (NASDAQ:AVXL) largest shareholders are individual investors with 60% ownership, institutions own 37%May 17, 2025 | finance.yahoo.comDoes Anavex's Alzheimer's Drug Actually Confer Benefit?May 15, 2025 | seekingalpha.comThe Unusual Effects Of Anavex's Blarcamesine On Alzheimer's Disease (Upgrade)May 15, 2025 | seekingalpha.comAnavex Life Sciences (NASDAQ:AVXL) Announces Quarterly Earnings ResultsAnavex Life Sciences (NASDAQ:AVXL - Get Free Report) announced its earnings results on Tuesday. The biotechnology company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.03. During the same period in the prior year, the company posted ($0.13) EPS.May 15, 2025 | marketbeat.comAnavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comAnavex Life Sciences Corp. Reports Q2 Fiscal 2025 Financial Results and Updates on Clinical DevelopmentsMay 15, 2025 | nasdaq.comAnavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2025 Earnings Call TranscriptMay 15, 2025 | insidermonkey.comAnavex Life Sciences Corp (AVXL) Q2 2025 Earnings Call Highlights: Promising Alzheimer's Data ...May 15, 2025 | finance.yahoo.comAnavex Life Sciences to Participate at Upcoming Healthcare ConferencesMay 14, 2025 | globenewswire.comAnavex Life Sciences Reports Fiscal 2025 Second Quarter Financial Results and Provides Business UpdateMay 13, 2025 | globenewswire.comAnavex Life Sciences Q2 2025 Earnings PreviewMay 13, 2025 | msn.comTudor Investment Corp ET AL Makes New $495,000 Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL)Tudor Investment Corp ET AL acquired a new stake in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 46,044 sharesMay 11, 2025 | marketbeat.comIs Anavex Life Sciences Corp. (AVXL) the Low Risk High Reward Stock Set to Triple by 2030?May 9, 2025 | msn.comAnavex Life Sciences (NASDAQ:AVXL) Stock Price Down 5.8% - Time to Sell?Anavex Life Sciences (NASDAQ:AVXL) Shares Down 5.8% - Here's WhyMay 7, 2025 | marketbeat.comAnavex Life Sciences to Announce Fiscal 2025 Second Quarter Financial Results on Tuesday, May 13, 2025May 6, 2025 | globenewswire.comAnavex Completes Enrollment For Phase 2 Schizophrenia Trial Of ANAVEX3-71May 3, 2025 | nasdaq.comAnavex Life Sciences (AVXL) Expected to Announce Quarterly Earnings on ThursdayAnavex Life Sciences (NASDAQ:AVXL) will be releasing its Q2 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-anavex-life-sciences-corp-stock/)May 3, 2025 | marketbeat.comWells Fargo & Company MN Decreases Position in Anavex Life Sciences Corp. (NASDAQ:AVXL)Wells Fargo & Company MN decreased its position in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 22.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 101,473 shares of the biotechnology company'sMay 2, 2025 | marketbeat.comAnavex Life Sciences Announces Full Enrollment of Phase 2 Study of ANAVEX®3-71 for the Treatment of SchizophreniaMay 1, 2025 | globenewswire.comMarshall Wace LLP Invests $1.52 Million in Anavex Life Sciences Corp. (NASDAQ:AVXL)Marshall Wace LLP acquired a new position in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 141,119 shares of the biotechnology companMay 1, 2025 | marketbeat.comAnavex Life Sciences to Participate in The Citizens Life Sciences ConferenceApril 30, 2025 | globenewswire.comRenaissance Technologies LLC Decreases Stock Holdings in Anavex Life Sciences Corp. (NASDAQ:AVXL)Renaissance Technologies LLC lowered its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 12.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 213,200 shares of the biotechnology company's stock after selApril 28, 2025 | marketbeat.comInvesco Ltd. Purchases 590,639 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)Invesco Ltd. boosted its position in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 2,419.8% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 615,048 shares of the biotechnology company's stock aftApril 28, 2025 | marketbeat.comAnavex appoints Audrey Gabelle to Scientific Advisory BoardApril 24, 2025 | markets.businessinsider.comAnavex Life Sciences Corp.: Anavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory BoardApril 23, 2025 | finanznachrichten.deAnavex Life Sciences Announces Appointment of Dr. Audrey Gabelle, MD, PhD to the Scientific Advisory BoardApril 23, 2025 | globenewswire.comJump Financial LLC Makes New $1.65 Million Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL)Jump Financial LLC acquired a new position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 153,231 shares of the biotechnology company's stock, valued at approximately $1,646,000. JuApril 22, 2025 | marketbeat.comXTX Topco Ltd Purchases Shares of 52,344 Anavex Life Sciences Corp. (NASDAQ:AVXL)XTX Topco Ltd acquired a new position in shares of Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 52,344 shares of the biotechnology company's stock, valued at approximately $56April 22, 2025 | marketbeat.comAnavex Life Sciences Corp (AVXL) Q1 2025 Earnings Call Highlights: Promising Alzheimer's Data ...April 21, 2025 | finance.yahoo.comAnavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer’s Disease and Related Disorders in the Middle EastApril 21, 2025 | markets.businessinsider.comAnavex Life Sciences Announces Presentation at 9th International Conference on Alzheimer's Disease and Related Disorders in the Middle EastApril 21, 2025 | globenewswire.comWellington Management Group LLP Makes New $1.70 Million Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL)Wellington Management Group LLP purchased a new stake in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 158,674 shares of the biotechnology cApril 15, 2025 | marketbeat.comVanguard Group Inc. Sells 59,727 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL)Vanguard Group Inc. trimmed its stake in Anavex Life Sciences Corp. (NASDAQ:AVXL - Free Report) by 1.3% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 4,680,444 shares of the biotechnology company's stock after selling 59,72April 14, 2025 | marketbeat.comAnavex: A Small Bit Of Progress Against Alzheimer's DiseaseApril 13, 2025 | seekingalpha.comAnavex Life Sciences (NASDAQ:AVXL) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $42.00 target price on shares of Anavex Life Sciences in a report on Monday.April 9, 2025 | marketbeat.comD. Boral Capital Reiterates "Buy" Rating for Anavex Life Sciences (NASDAQ:AVXL)D. Boral Capital reiterated a "buy" rating and set a $46.00 price objective on shares of Anavex Life Sciences in a research note on Monday.April 9, 2025 | marketbeat.comAnavex: Understanding Their Alzheimer's Open-Label Extension Data SkepticallyApril 7, 2025 | seekingalpha.comAnavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer’s DiseaseApril 7, 2025 | seekingalpha.comAnavex Life Sciences Reports Long-Term Blarcamesine Benefits For Early Alzheimer's PatientsApril 7, 2025 | nasdaq.comAnavex announces results from Phase IIb/III open-label extension trialApril 6, 2025 | markets.businessinsider.comAnavex Life Sciences Corp. Common Stock (AVXL) SEC FilingsApril 6, 2025 | nasdaq.comAnavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's DiseaseApril 5, 2025 | globenewswire.comAnavex Life Sciences (NASDAQ:AVXL) Trading 7.2% Higher - Still a Buy?Anavex Life Sciences (NASDAQ:AVXL) Shares Up 7.2% - Should You Buy?April 4, 2025 | marketbeat.comAnavex Life Sciences (NASDAQ:AVXL) Stock Price Down 6.9% - What's Next?Anavex Life Sciences (NASDAQ:AVXL) Stock Price Down 6.9% - What's Next?April 3, 2025 | marketbeat.com Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address AVXL Media Mentions By Week AVXL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVXL News Sentiment▼1.760.88▲Average Medical News Sentiment AVXL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVXL Articles This Week▼44▲AVXL Articles Average Week Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MLTX News IMVT News HCM News AAPG News XENE News OGN News AMRX News IBRX News APLS News MIRM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVXL) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
